No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
CRISPR Therapeutics Stock Pops Following Disclosure of RFK Jr. Investment
Google Parent-Owned Startup To Launch AI-Designed Drug Trials By Year-End, Partnering With Eli Lilly And Novartis To Tackle Major Diseases
Cathie Wood's Ark Invest Is Betting Big On This AI Darling And No It's Not Nvidia
CRISPR Therapeutics AG (CRSP): The Biotech Stock With Biggest Upside Potential
CRISPR Therapeutics Stock Falls 34% in a Year: Time to Buy or Sell?
Cathie Wood's ARK Invest Boosts CRISPR Therapeutics (NASDAQ:CRSP) Stake